Bloom Energy Surges 12 on 26 Billion Partnership with European AI Infrastructure Firm Nebius Infrastructure Control Emerges as Potential Next Frontier for Financial Advantage Global Leaders Closely Monitor Potential TrumpXi Summit for Trade and Geopolitical Signals Treasury Yield Surge Prompts Bond Investors to Seek Better Opportunities in Intermediates BBBs and High Yield Andy Burnhams Manchester Vision A Model for Regional Economic Policy and Investment Potential BP Shares Slide After Board Ousts Chairman in Surprise Move Clearway Energy Q1 2026 Earnings Substantial EPS Miss Amid Operational Volatility TMCI Q1 2026 Earnings EPS Beat Surprises Analysts Stock Declines Slightly Sachem Capital Corp 600 Notes due 2027 SCCE Q4 2025 Earnings Massive EPS Surprise Highlights Resilient Operating Performance MSGE Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain Sachem Capital Corp SCCF Q4 2025 Earnings EPS Surges Past Estimates Notes Edge Higher GFL Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Weigh GigaCloud Technology GCT Holds Steady Near Support Sideways Trading Signals Caution Bold Eagle Acquisition Corp BEAG Inches Up Amid Stable SPAC Trading BrightSpring Health Services BTSGU Holds Steady Near Support Amid Modest Pullback ZTO Express ZTO Shares Edge Higher Amid Mixed Sentiment Key Levels to Watch Manitowoc MTW Slips 1 as It Tests Key Support Levels Near 11 ERAS Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Climbs Keysight Q1 2026 Earnings Significant EPS Beat Fails to Lift Sentiment Atlanta Braves Holdings Inc Series C BATRK Q1 2026 Earnings EPS Surprises Positively in Seasonally Quiet Quarter FEED Q1 2026 Earnings Reported EPS of 688 Stock Declines on Widening Losses Safehold Inc SAFE Q1 2026 Earnings EPS Miss Weighs on Shares Despite Stable Ground Lease Portfolio AAR Corp AIR Q1 2026 Earnings EPS Surges Past Estimates as Aftersales Momentum Continues Reddit Reports 69 Revenue Surge Topping Analyst Estimates LENZ Q1 2026 Earnings EPS Misses Estimates as Development Costs Persist Immix Biopharma IMMX Edges Lower in Consolidation Phase Eyes Key Support at 829